Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 9.18
-0.30 (-3.16%)
Mar 23, 2026, 10:34 AM CET
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of 2.67 billion as of March 23, 2026. Its market cap has increased by 51.29% in one year.
Market Cap
2.67B
Enterprise Value
1.50B
Revenue
3.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.18
Market Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from 87.82M to 2.67B, an increase of 2,939.14%. That is a compound annual growth rate of 39.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.67B | -16.11% |
| Dec 30, 2025 | 3.18B | 60.49% |
| Dec 30, 2024 | 1.98B | 25.12% |
| Dec 29, 2023 | 1.58B | 8.13% |
| Dec 30, 2022 | 1.47B | 46.67% |
| Dec 30, 2021 | 998.90M | -47.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 2.99B |
| Flerie AB | 2.79B |
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 2.02B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |